MASI News Alert Masimo Corp (MASI) 27.38 02/14/2015 00:05:18

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:05 AM

Masimo Corp (MASI) 27.38 $MASI

Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:30AM CST
Our proven model does not conclusively show that Masimo Corp (MASI) is likely to beat earnings this quarter.
BLUE: 90.70 (+0.93), ACT: 285.37 (+3.71), MASI: 27.38 (-0.21), HLS: 45.01 (+0.30)

National Fire Protection Association Issues Updated Standard Requiring Firefighters Exposed to Fire Smoke to Be Assessed for Carbon Monoxide Poisoning at Incident Scenes and During Training
Marketwired - Thu Feb 12, 7:04AM CST
Masimo (NASDAQ: MASI), the inventor of Masimo SET(R) Measure-Through Motion and Low Perfusion(TM) pulse oximetry and rainbow(R) Pulse CO-Oximetry, announced today that the National Fire Protection Association (NFPA) released an updated Fire Rehabilitation Standard (NFPA 1584) requiring firefighters exposed to smoke at incident scenes and during training to be assessed for carbon monoxide (CO) poisoning.
MASI: 27.38 (-0.21)

Shares of MASI Up 11.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 09, 9:56AM CST
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on October 30th, 2014 at $24.11. In approximately 3 months, Masimo has returned 11.95% as of today's recent price of $26.99.
MASI: 27.38 (-0.21)

Masimo reports February 17
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 9:12AM CST

MASI: 27.38 (-0.21)

Masimo to Report Fourth Quarter 2014 Financial Results After Market Close on Tuesday, February 17th
Marketwired - Fri Jan 30, 8:00AM CST
Masimo (NASDAQ: MASI) announced today that it will release financial results for the fourth quarter ended January 3, 2015, after the market closes on Tuesday, February 17, 2015. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
MASI: 27.38 (-0.21)

Inova Fair Oaks Hospital Casts Masimo Patient SafetyNet(TM) to Help Improve Patient Outcomes and Reduce Costs
Marketwired - Wed Jan 14, 10:12AM CST
Masimo (NASDAQ: MASI) and Inova Fair Oaks Hospital -- listed among the 2014 Truven Health Analytics Top 100 Hospitals(R) for delivering the best care in its community -- announced that the hospital has installed Masimo Patient SafetyNet(TM), a remote monitoring and clinician notification system shown to keep patients safer while reducing cost of care.(1)
MASI: 27.38 (-0.21)

Masimo Up 14.4% Since SmarTrend Uptrend Call (MASI)
Comtex SmarTrend(R) - Fri Jan 09, 9:34AM CST
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on October 30th, 2014 at $24.11. In approximately 2 months, Masimo has returned 14.43% as of today's recent price of $27.59.
MASI: 27.38 (-0.21)

Masimo Launches MightySat Pulse Oximeter for Personal Use - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 5:10PM CST
Masimo Corporation's (MASI) MightySat is the first fingertip pulse oximeter available with Masimo SET Measure-through Motion and Low Perfusion pulse oximetry.
ABMD: 60.39 (+0.46), MASI: 27.38 (-0.21), COV: 106.71 (-1.36), SURG: 4.44 (-0.02)

Masimo Unveils MightySat(TM) at Consumer Electronics Show -- First Fingertip Pulse Oximeter With Masimo SET(R) Measure-through Motion and Low Perfusion(TM) Technology
Marketwired - Mon Jan 05, 7:03AM CST
Masimo (NASDAQ: MASI) today announced the MightySat fingertip pulse oximeter for personal use. MightySat provides accurate oxygen saturation and pulse rate measurements when other pulse oximeters can fail(1) and is ideal for those who want reliable measurements even under extreme conditions.
MASI: 27.38 (-0.21)

Masimo Unveils MightySat(TM) at Consumer Electronics Show-First Fingertip Pulse Oximeter With Masimo SET(R) Measure-through Motion and Low Perfusion(TM) Technology
Marketwire Canada - Mon Jan 05, 7:01AM CST
Masimo (NASDAQ: MASI) today announced the MightySat fingertip pulse oximeter for personal use. MightySat provides accurate oxygen saturation and pulse rate measurements when other pulse oximeters can fail(1) and is ideal for those who want reliable measurements even under extreme conditions.
MASI: 27.38 (-0.21)

Masimo to Present at 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Tue Dec 30, 8:00AM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 13, 2015, at 4:30 p.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
MASI: 27.38 (-0.21), JPM: 59.67 (+0.10)

Pulse Oximeters: Pulse Oximeter Monitors & Sensors - 2014 Global Strategic Business Report
M2 - Thu Dec 18, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/5c6rrn/pulse_oximeters) has announced the addition of the "Pulse Oximeters - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousands by the following Product Segments: - Pulse Oximeter Monitors - Sensors The market for 'Pulse Oximeter Monitors' is analyzed by the following Product Types and End-Use Segments and covers non-invasive pulse oximeters only: - Product Types: Stand-Alone Devices, (Bedside Devices, & Handheld Devices), and Multiparameter Units - End-Use Segments: Hospital Care (Stand-Alone, & Multiparameter), and Alternate Care (Stand-Alone, & Multiparameter). The report profiles 100 companies including many key and niche players such as: - CAS Medical Systems, Inc. - Covidien Plc - Masimo Corporation - Nihon-Kohden Corp. - Nonin Medical, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Dynamics 3. Market Trends & Issues 4. Application Overview 5. Competitive Landscape 6. Product Overview 7. Product Innovations/Introductions 8. Recent Industry Activity 9. Focus On Select Global Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 100 (including Divisions/Subsidiaries 112) - The United States (47) - Canada (1) - Japan (6) - Europe (22) - Germany (9) - The United Kingdom (5) - Italy (4) - Spain (1) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (35) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5c..._oximeters
MASI: 27.38 (-0.21), CASM: 1.36 (-0.01)

Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:55PM CST
Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform.
MASI: 27.38 (-0.21), GMED: 24.85 (+0.45), COV: 106.71 (-1.36), EW: 134.23 (+1.89)

Masimo Announces Global Launch of Multigas Monitoring for the Root(R) Patient Monitoring and Connectivity Platform
Marketwired - Tue Dec 16, 7:03AM CST
Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance and CE Mark of ISA(TM) OR+ multigas monitoring, a Masimo Open Connect (MOC-9) Module for the Root(R) patient monitoring and connectivity platform. During general anesthesia, the ISA OR+ monitors the inhaled and exhaled concentration of five anesthetic gas agents (Sevoflurane, Isoflurane, Halothane, Desflurane, Enflurane), carbon dioxide (CO2), nitrous oxide (N2O), and oxygen (O2), in addition to respiration rate. When technology modules are connected with Root, multiple additional parameters are available including Masimo SET(R) pulse oximetry, noninvasive and continuous hemoglobin (SpHb(R)), PVI(R), SedLine(R) brain function monitoring, and O3(TM) Regional Oximetry.*
MASI: 27.38 (-0.21)

Masimo Receives 2014 Zenith Award at the American Association of Respiratory Care Congress
Marketwired - Wed Dec 10, 7:02AM CST
Masimo (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-through Motion and Low Perfusion(TM) pulse oximetry, announced today that it has received the prestigious Zenith Award for equipment and service excellence from the American Association of Respiratory Care (AARC) at the 60th Annual AARC Congress in Las Vegas, Nev.
MASI: 27.38 (-0.21)

Masimo iSpO2(TM) Pulse Oximeter Featured in Fitness Book by Tour de France Champion Greg LeMond
Marketwired - Thu Dec 04, 10:01AM CST
Masimo (NASDAQ: MASI) today announced that its award-winning iSpO2(TM) pulse oximeter is featured in the upcoming book "The Science of Fitness: Power, Performance, and Endurance," by three-time Tour de France champion Greg LeMond and co-author interventional radiologist Dr. Mark Hom, available at Amazon.com and the Elsevier Store.
MASI: 27.38 (-0.21)

Masimo's Radius-7 Monitor Gets FDA Nod, Rivalry Intensifies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 6:00PM CST
Manufacturer of patient monitoring products, Masimo Corp. (MASI) recently announced Food and Drug Administration (FDA)'s clearance of the company's Radius-7 wireless monitor.
BABY: 36.96 (-0.03), MASI: 27.38 (-0.21), CASM: 1.36 (-0.01), COV: 106.71 (-1.36)

FDA clears Masimo wireless patient monitor
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 2:39PM CST

MASI: 27.38 (-0.21)

Masimo Announces FDA 510(k) Clearance of Radius-7(TM)-First rainbow(R) SET(R) Noninvasive Wearable, Wireless Monitor for Root(R)
Marketwire Canada - Mon Dec 01, 12:22PM CST
Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance of Radius-7(TM) for the Root(R) patient monitoring and connectivity platform, the first and only wearable, wireless monitor with Masimo's breakthrough rainbow(R) SET(R) technology, offering patients continuous monitoring with freedom of movement.
MASI: 27.38 (-0.21)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

VISTAR Oakland Workers Join Teamsters for Unity

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

TomoIQ Unveils Money Finder at Money20/20 Event

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

U.S. Millionaire Surge: Market Waves or Mirage?

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Noé Hinojosa Jr. Honored for Leadership in Business

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...